Contact — Clinic Retatrutide

Contact

Clinic Retatrutide is an independent editorial publication. We summarize the peer-reviewed research literature on retatrutide — the investigational triple-receptor agonist under Phase 3 TRIUMPH trials. We are not a clinic, not a pharmacy, not a vendor, and not a medical practice. We do not prescribe, dispense, recommend, or sell any compound.

For questions about the editorial content on this site, corrections to citations, or general correspondence, use the form below. We respond to editorial correspondence.

We cannot respond to requests for medical advice, dosing guidance, vendor referrals, or clinical trial enrollment assistance. For clinical trial enrollment in Lilly-sponsored TRIUMPH trials, visit ClinicalTrials.gov and search for NCT05651776 or related TRIUMPH trial identifiers.

All content on this site is editorial commentary on publicly available, peer-reviewed research. Nothing here constitutes medical advice, a treatment recommendation, or an endorsement of any specific use of retatrutide outside authorized clinical trial protocols.